Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen

NCT03023020 is registered in ClinicalTrials.gov with ECRI bv as lead sponsor.

NCT NCT03023020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03023020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
Lead sponsor
ECRI bv
Phase
Not applicable
Overall status
Completed
Start date
April 4, 2017
Completion date
April 30, 2021
Enrollment
4,579 (actual)
Sites
138

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, high bleeding risk, pci